Cravath, Latham Craft $8B Deal For Cancer Detection Biz
Biotechnology firm Illumina Inc. has agreed to buy Grail, a publicly traded cancer detection company it founded back in 2016, for roughly $8 billion, the two California-based companies said Monday, in...To view the full article, register now.
Already a subscriber? Click here to view full article